Argos Therapeutics, Inc.
USD0.27
+0.01 (+1.89%)
IPO Date
2014-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.27
Prev. Close
$0.27
Day Low
$0.25
Day High
$0.28
52W Low
$0.13
52W High
$3.89
Volume
0.76M
| 67,887 |
| $0.00 |
| 25 Apr 2018 | Nicolette Charles A. | CSO and Vice President of R&D | D-Return | Disposed | 27,150 | $0.00 |
| 25 Apr 2018 | Katz Richard D | Vice President and CFO | D-Return | Disposed | 22,629 | $0.00 |
| 2 Apr 2018 | Katz Richard D | Vice President and CFO | A-Award | Acquired | 22,629 | $0.00 |
| 30 Mar 2018 | Harrelson Lori R. | Vice President of Finance | A-Award | Acquired | 22,629 | $0.00 |
| 30 Mar 2018 | Abbey Jeffrey D | director, officer: Chief Executive Officer | A-Award | Acquired | 67,887 | $0.00 |
| 30 Mar 2018 | Nicolette Charles A. | CSO and Vice President of R&D | A-Award | Acquired | 27,150 | $0.00 |
| 12 Jan 2018 | Harrelson Lori R. | Vice President of Finance | S-Sale | Disposed | 64,329 | $0.16 |
| 12 Jan 2018 | Harrelson Lori R. | Vice President of Finance | S-Sale | Disposed | 64,329 | $0.16 |